Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ImmunoCellular Therapeutics Ltd. (IMUC)

0.03   0.001 (3.45%) 07-01 14:52
Open: 0.024 Pre. Close: 0.029
High: 0.03 Low: 0.024
Volume: 191,738 Market Cap: 1M
ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.03 - 0.03 0.03 - 0.03
Low: 0.02 - 0.02 0.02 - 0.02
Close: 0.03 - 0.03 0.03 - 0.03

Technical analysis

as of: 2020-07-01 4:33:59 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.04     One year: 0.04
Support: Support1: 0.02    Support2: 0.02
Resistance: Resistance1: 0.03    Resistance2: 0.04
Pivot: 0.03
Moving Average: MA(5): 0.03     MA(20): 0.02
MA(100): 0.03     MA(250): 0.03
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 83.33     %D(3): 76.39
RSI: RSI(14): 64.26
52-week: High: 0.05  Low: 0.01  Change(%): 60.4
Average Vol(K): 3-Month: 8111  10-Days: 17199

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IMUC has closed above the upper band by 14.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 16.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Jun 2020
Dendritic Cell Therapy Market To Grow During 2020-2028 On Account Of Increasing Awareness Among People About Cancer Treatments - Cole of Duty

Wed, 16 Oct 2019
ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit - PRNewswire

Wed, 28 Aug 2019
ImmunoCellular Therapeutics Announces Completion of Asset Purchase Transaction with Private Biotechnology Company - PRNewswire

Fri, 09 Aug 2019
ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action - GlobeNewswire

Tue, 16 Jul 2019
ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company - PRNewswire

Fri, 22 Mar 2019
Wolf Popper LLP Announces a Proposed Class Action Settlement for all Persons Who Purchased or Otherwise Acquired ImmunoCellular Therapeutics, Ltd. (“IMUC”) Common Stock - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 42
Shares Float (M) 42
% Held by Insiders
% Held by Institutions
Shares Short (K) 1,740
Shares Short P. Month (K) 1,940

Stock Financials

EPS -0.269
EPS Est This Year -3.830
EPS Est Next Year -0.640
Book Value (p.s.) 0.080
Profit Margin
Operating Margin
Return on Assets (ttm) -88.1
Return on Equity (ttm) -2312.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.145
Qtrly Earnings Growth
Operating Cash Flow (M) -11
Levered Free Cash Flow (M) -9

Stock Valuations

PE Ratio -0.11
PEG Ratio
Price to Book value 0.38
Price to Sales
Price to Cash Flow -0.12

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.